Literature DB >> 2112580

Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.

J C Khoo1, E Miller, P McLoughlin, D Steinberg.   

Abstract

We have shown previously that low density lipoprotein (LDL) subjected to vortexing forms self-aggregates that are avidly phagocytosed by macrophages. That phagocytic uptake is mediated by the LDL receptor. We now show that LDL self-aggregation is strongly inhibited (80-95%) by the presence of high density lipoprotein (HDL) or apolipoprotein (apo) A-I. Another type of LDL aggregation, namely that induced by incubation of LDL with phospholipase C, was also markedly inhibited by HDL or apoA-I. The aggregation of LDL induced by vortexing was not inhibited by 2.5 M NaCl, and apoA-I was still able to block LDL aggregation at this high salt concentration, strongly suggesting hydrophobic interactions as the basis for the effect of apoA-I. The fact that apoA-I protected against LDL aggregation induced by two apparently quite different procedures suggests that the aggregation in these two cases has common features. We propose that these forms of LDL aggregation result from the exposure of hydrophobic domains normally masked in LDL and that the LDL-LDL association occurs when these domains interact. ApoA-I, because of its amphipathic character, is able to interact with the exposed hydrophobic domains of LDL and thus block the intermolecular interactions that cause aggregation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112580

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

1.  The mechanism of oxidation-induced low-density lipoprotein aggregation: an analogy to colloidal aggregation and beyond?

Authors:  S Xu; B Lin
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

Authors:  David O Osei-Hwedieh; Marcelo Amar; Dmitri Sviridov; Alan T Remaley
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

3.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

4.  Activation of T-lymphocytes by LDL-cholesterol.

Authors:  Borros Arneth
Journal:  Lipids       Date:  2008-12-17       Impact factor: 1.880

5.  Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.

Authors:  Ramya Ganesan; Karen M Henkels; Lucile E Wrenshall; Yasunori Kanaho; Gilbert Di Paolo; Michael A Frohman; Julian Gomez-Cambronero
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

6.  Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis.

Authors:  Mengxiao Lu; Donald L Gantz; Haya Herscovitz; Olga Gursky
Journal:  J Lipid Res       Date:  2012-07-31       Impact factor: 5.922

Review 7.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

8.  Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.

Authors:  Anna Rull; Shobini Jayaraman; Donald L Gantz; Andrea Rivas-Urbina; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta       Date:  2016-05-24

9.  Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.

Authors:  Su Duy Nguyen; Matti Javanainen; Sami Rissanen; Hongxia Zhao; Jenni Huusko; Annukka M Kivelä; Seppo Ylä-Herttuala; Mohamad Navab; Alan M Fogelman; Ilpo Vattulainen; Petri T Kovanen; Katariina Öörni
Journal:  J Lipid Res       Date:  2015-04-10       Impact factor: 5.922

10.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Authors:  S L Schissel; J Tweedie-Hardman; J H Rapp; G Graham; K J Williams; I Tabas
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.